Depression, inflammation, and pain in patients with rheumatoid arthritis

Arthritis Care and Research

Volumn 61, Issue 8, 2009, Pages 1018-1024

  Kojima, Masayo ^a   Kojima, Toshihisa ^b   Suzuki, Sadao ^a   Oguchi, Takeshi ^b   Oba, Michinari ^b   Tsuchiya, Hiroki ^b   Sugiura, Fumiaki ^b   Kanayama, Yasuhide ^b   Furukawa, Toshiaki A ^a   Tokudome, Shinkan ^a   Ishiguro, Naoki ^b  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; DEPRESSION; DEPRESSION INVENTORY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; OUTCOME ASSESSMENT; OUTPATIENT; PAIN; PAIN ASSESSMENT; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SELF CONCEPT; SYMPTOM; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; DEPRESSION; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 68149182498     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.24647     Document Type: Article

References (46)

1. Harris ED Jr. Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-1289 (Pubitemid 20152491)
2. Cohen S, Rodriquez MS. Pathways linking affective disturbances and physical disorders. Health Psychol 1995;14:374-380
3. Dickens C, McGowan L, Dale S. Impact of depression on experimental pain perception: a systematic review of the literature with meta-analysis. Psychosom Med 2003;65:369-375 (Pubitemid 36628889)
4. Sleath B, Chewning B, de Vellis BM, Weinberger M, de Vellis RF, Tudor G, et al. Communication about depression during rheumatoid arthritis patient visits. Arthritis Rheum 2008;59:186-191 (Pubitemid 351272953)
5. Ang DC, Choi H, Kroenke K, Wolfe F. Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol 2005;32:1013-1019 (Pubitemid 40828071)
6. Kuo HK, Yen CJ, Chang CH, Kuo CK, Chen JH, Sorond F. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol 2005;4:371-380 (Pubitemid 40720034)
7. De Berardis D, Campanella D, Gambi F, La Rovere R, Carano A, Conti CM, et al. The role of C-reactive protein in mood disorders. Int J Immunopathol Pharmacol 2006;19:721-725 (Pubitemid 46145036)
8. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009;71:171-186
9. Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res 2002;53:897-902.
10. Frasure-Smith N, Lesperance F, Irwin MR, Sauve C, Lesperance J, Theroux P. Depression, C-reactive protein and twoyear major adverse cardiac events in men after acute coronary syndromes. Biol Psychiatry 2007;62:302-308
11. Maier SF, Watkins LR. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998;105:83-107.
12. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24-31. (Pubitemid 43083561)
13. Herbert TB, Cohen S. Depression and immunity: a meta-analytic review. Psychol Bull 1993;113:472-486
14. Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001;15:199-226. (Pubitemid 33070955)
15. Zautra AJ, Smith BW. Depression and reactivity to stress in older women with rheumatoid arthritis and osteoarthritis. Psychosom Med 2001;63:687-696
16. Merskey H, Lindblom U, Mumford JM. Pain terms: a current list with definitions and notes on usage. Pain 1986;Suppl 3:215-221
17. Clark MR, Treisman GJ. Perspectives on pain and depression. In: Clark MR, Treisman GJ, editors. Pain and depression. Basel (Switzerland): Karger; 2006. p. 1-27.
18. Dersh J, Polatin PB, Gatchel RJ. Chronic pain and psychopathology: research findings and theoretical considerations. Psychosom Med 2002;64:773-786
19. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain 1997;13:116-137 (Pubitemid 27251106)
20. Tunks ER, Weir R, Crook J. Epidemiologic perspective on chronic pain treatment. Can J Psychiatry 2008;53:235-242 (Pubitemid 351838517)
21. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002;46:328-346 (Pubitemid 34136570)
22. Kojima M, Kojima T, Ishiguro N, Oguchi T, Oba M, Tsuchiya H, et al. Psychosocial factors, disease status, and quality of life in patients with rheumatoid arthritis. J Psychosom Res. In press.
23. Beck AT, Steer RA. Manual for the Beck Depression Inventory-II. San Antonio (TX): Psychological Corporation; 1996.
24. Kojima M, Furukawa TA, Takahashi H, Kawai M, Nagaya T, Tokudome S. Cross-cultural validation of the Beck Depression Inventory-II in Japan. Psychiatry Res 2002;110:291-299 (Pubitemid 34804537)
25. Hiroe T, Kojima M, Yamamoto I, Nojima S, Kinoshita Y, Hashimoto N, et al. Gradations of clinical severity and sensitivity to change assessed with the Beck Depression Inventory-II in Japanese patients with depression. Psychiatry Res 2005;135:229-235 (Pubitemid 40984614)
26. Steinbroker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-662
27. Eda S, Kaufmann J, Molwitz M, Vorberg E. A new method of measuring C-reactive protein, with a low limit of detection, suitable for risk assessment of coronary heart disease. Scand J Clin Lab Invest Suppl 1999;230:32-35 (Pubitemid 29279353)
28. Dantzer R. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur J Pharmacol 2004;500:399-411. (Pubitemid 39304023)
29. Pace MC, Mazzariello L, Passavanti MB, Sansone P, Barbarisi M, Aurilio C. Neurobiology of pain. J Cell Physiol 2006;209:8-12.
30. Loeser JD, Melzack R. Pain: an overview. Lancet 1999;353:1607-1609
31. Jann MW, Slade JH. Antidepressant agents for the treatment of chronic pain and depression. Pharmacotherapy 2007;27:1571-1587 (Pubitemid 350060211)
32. Clark MR, Treisman GJ. Neurobiology of pain. In: Clark MR, Treisman GJ, editors. Pain and depression. Basel (Switzerland): Karger; 2006. p. 78-88.
33. Neugebauer V, Li W, Bird GC, Han JS. The amygdala and persistent pain. Neuroscientist 2004;10:221-234
34. Melamed S, Shirom A, Toker S, Berliner S, Shapira I. Association of fear of terror with low-grade inflammation among apparently healthy employed adults. Psychosom Med 2004;66:484-491 (Pubitemid 38971241)
35. Bankier B, Barajas J, Martinez-Rumayor A, Januzzi JL. Association between C-reactive protein and generalized anxiety disorder in stable coronary heart disease patients. Eur Heart J 2008;29:2212-2217
36. Stewart JC, Janicki-Deverts D, Muldoon MF, Kamarck TW. Depressive symptoms moderate the influence of hostility on serum interleukin-6 and C-reactive protein. Psychosom Med 2008;70:197-204. (Pubitemid 351252968)
37. Corcos M, Guilbaud O, Paterniti S, Curt F, Hjalmarsson L, Moussa M, et al. Correlation between serum levels of interleukin-4 and alexithymia scores in healthy female subjects: preliminary findings. Psychoneuroendocrinology 2004;29:686-691 (Pubitemid 38369169)
38. De Berardis D, Serroni N, Campanella D, Carano A, Gambi F, Valchera A, et al. Alexithymia and its relationships with C-reactive protein and serum lipid levels among drug naïve adult outpatients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1982-1986
39. Sifneos PE. Clinical observations on some patients suffering from a variety of psychosomatic diseases. Acta Med Psychosomatica 1967;7:1-10.
40. Taylor GJ, Bagby RM. New trends in alexithymia research. Psychother Psychosom 2004;73:68-77.
41. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest 2007;131:1557-1566
42. Paperwalla KN, Levin TT, Weiner J, Saravay SM. Smoking and depression. Med Clin North Am 2004;88:1483-1494
43. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. 'Vascular depression' hypothesis. Arch Gen Psychiatry 1997;54:915-922
44. Bartfai T, Waalen J, Buxbaum JN. Adipose tissue as a modulator of clinical inflammation: does obesity reduce the prevalence of rheumatoid arthritis? J Rheumatol 2007;34:488-492
45. Miller GE, Freedland KE, Carney RM, Stetler CA, Banks WA. Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun 2003;17:276-285
46. Douglas KM, Taylor AJ, O'Malley PG. Relationship between depression and C-reactive protein in a screening population. Psychosom Med 2004;66:679-683 (Pubitemid 39332353)